Fundraising Fox
/Investor DB
Sign in

Beacon Angels — 2026 Investments

1 investments dated 2026 · listed companies and verified rows first · show all

GelMEDIXgelmedix.cominFeb 2026

GelMEDIX is a Cambridge-based biotech developing injectable hydrogel-based cell and gene therapies for vision-restoring retinal treatment.

BiotechCambridge, US

Max Cotler(Executive Officer)inNasim Annabi(Director)Reza Dana(Director)Arthur Driscoll(Executive Officer, Director)

BoardMichael Cima(Director)Parinaz Motamedy(Director)in

Co-investorsBoston Harbor AngelsEQx FundSafar Partners

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.